Influence of the tumor site and histopathology after resection for non-colorectal non-neuroendocrine liver metastases. A single center experience
Copyright © 2022. Published by Elsevier España, S.L.U..
INTRODUCTION: It remains unclear whether liver resection is justified in patients with non-colorectal non-neuroendocrine liver metastases (NCNNLM). A single-center study was conducted to analyse overall survival (OS), disease-free survival (DFS), and potential prognostic factors in patients with different types of NCNNLM.
METHOD: A retrospective analysis of all patients who underwent liver resection of NCNNLM from January 2006 to July 2019 was performed.
RESULTS: A total of 62 patients were analyzed. 82.3% presented metachronous metastases and 74.2% were unilobar. The most frequent primary tumor site (PTS) were breast (24.2%), urinary tract (19.4%), melanoma (12.9%), and pancreas (9.7%). The most frequent primary tumor pathologies were breast carcinoma (24.2%), non-breast adenocarcinoma (21%), melanoma (12.9%) and sarcoma (12.9%). The most frequent surgical procedure performed was minor hepatectomy (72.6%). R0 resection was achieved in 79.5% of cases. The major complications' rate was 9.7% with a 90-day mortality rate of 1.6%. The 1, 3 and 5-year OS/DFS rate were 65%/28%, 45%/36% and 46%/28%, respectively. We identified the response to neoadjuvant therapy and PTS as possible prognostic factors for OS (P =0.06) and DFS (P =0.06) respectively.
CONCLUSION: Based on the results of our series, NCNNLM resection produces beneficial outcomes in terms of OS and DFS. PTS and the response to neoadjuvant therapy could be the main prognostic factors after resection.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:101 |
|---|---|
| Enthalten in: |
Cirugia espanola - 101(2023), 6 vom: 15. Juni, Seite 397-407 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
De-Armas-Conde, Noelia [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Hepatectomía |
|---|
| Anmerkungen: |
Date Completed 27.06.2023 Date Revised 27.06.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.cireng.2022.04.016 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM340295201 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM340295201 | ||
| 003 | DE-627 | ||
| 005 | 20231226004823.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.cireng.2022.04.016 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1134.xml |
| 035 | |a (DE-627)NLM340295201 | ||
| 035 | |a (NLM)35500759 | ||
| 035 | |a (PII)S2173-5077(22)00091-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a De-Armas-Conde, Noelia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Influence of the tumor site and histopathology after resection for non-colorectal non-neuroendocrine liver metastases. A single center experience |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.06.2023 | ||
| 500 | |a Date Revised 27.06.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022. Published by Elsevier España, S.L.U. | ||
| 520 | |a INTRODUCTION: It remains unclear whether liver resection is justified in patients with non-colorectal non-neuroendocrine liver metastases (NCNNLM). A single-center study was conducted to analyse overall survival (OS), disease-free survival (DFS), and potential prognostic factors in patients with different types of NCNNLM | ||
| 520 | |a METHOD: A retrospective analysis of all patients who underwent liver resection of NCNNLM from January 2006 to July 2019 was performed | ||
| 520 | |a RESULTS: A total of 62 patients were analyzed. 82.3% presented metachronous metastases and 74.2% were unilobar. The most frequent primary tumor site (PTS) were breast (24.2%), urinary tract (19.4%), melanoma (12.9%), and pancreas (9.7%). The most frequent primary tumor pathologies were breast carcinoma (24.2%), non-breast adenocarcinoma (21%), melanoma (12.9%) and sarcoma (12.9%). The most frequent surgical procedure performed was minor hepatectomy (72.6%). R0 resection was achieved in 79.5% of cases. The major complications' rate was 9.7% with a 90-day mortality rate of 1.6%. The 1, 3 and 5-year OS/DFS rate were 65%/28%, 45%/36% and 46%/28%, respectively. We identified the response to neoadjuvant therapy and PTS as possible prognostic factors for OS (P =0.06) and DFS (P =0.06) respectively | ||
| 520 | |a CONCLUSION: Based on the results of our series, NCNNLM resection produces beneficial outcomes in terms of OS and DFS. PTS and the response to neoadjuvant therapy could be the main prognostic factors after resection | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Hepatectomy | |
| 650 | 4 | |a Hepatectomía | |
| 650 | 4 | |a Liver neoplasm | |
| 650 | 4 | |a Liver resection | |
| 650 | 4 | |a Metastases | |
| 650 | 4 | |a Metástasis | |
| 650 | 4 | |a Neoplasia hepática | |
| 650 | 4 | |a No colorrectal no neuroendocrino | |
| 650 | 4 | |a Non colorectal non neuroendocrine | |
| 650 | 4 | |a Resección hepática | |
| 700 | 1 | |a Ramon-Rodriguez, Julen |e verfasserin |4 aut | |
| 700 | 1 | |a Prada-Villaverde, Aranzazu |e verfasserin |4 aut | |
| 700 | 1 | |a Jaén-Torrejimeno, Isabel |e verfasserin |4 aut | |
| 700 | 1 | |a López-Guerra, Diego |e verfasserin |4 aut | |
| 700 | 1 | |a Blanco-Fernández, Gerardo |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cirugia espanola |d 2012 |g 101(2023), 6 vom: 15. Juni, Seite 397-407 |w (DE-627)NLM223248274 |x 2173-5077 |7 nnns |
| 773 | 1 | 8 | |g volume:101 |g year:2023 |g number:6 |g day:15 |g month:06 |g pages:397-407 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cireng.2022.04.016 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 101 |j 2023 |e 6 |b 15 |c 06 |h 397-407 | ||